• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

VAL:LN

0.3950 GBp 0.0050 1.28%

As of 11:30:00 ET on 08/20/2014.

Snapshot for ValiRx PLC (VAL)

Open: 0.3850 Day's Range: 0.3650 - 0.4150 Volume: 22,752,082
Previous Close: 0.3900 52wk Range: 0.2550 - 0.7100 1-Yr Rtn: 0.00%

Stock Chart for VAL

No chart data available.
  • VAL:LN 0.3950
  • 1D
  • 1M
  • 1Y
0.3900
Interactive VAL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VAL

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. UKX -
Earnings Per Share (GBP) (ttm) -0.0010
Est. EPS (GBP) (12/2014) -0.0010
Est. PEG Ratio -
Market Cap (M GBP) 11.54
Shares Outstanding (M) 2,921.04
30 Day Average Volume 33,198,730
Price/Book (mrq) 1.9731
Price/Sale (ttm) 114.0190
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VAL

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for VAL

ValiRx PLC, through subsidiaries, develops biopharmaceutical and biomedical therapeutics and diagnositcs. The Company develops treatments and diagnostics for cancer, and an adult stem cell isolation and purification device.

Satu VainikkaChief Executive OfficerGerald Desler "Gerry"Chief Financial Officer
George MorrisChief Operating OfficerKevin J AlexanderSecretary
More Company Profile & Key Executives for VAL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil